Hannaleena Eerola - Concepedia

Author

Hannaleena Eerola

Helsinki University Hospital

Also Known As

H Eerola, H. Eerola, Hannaleena Eerola, Rainer Fagerholm

Publications

9.2K

Citations

H-Index

Concepts

All Affiliations

Helsinki University Hospital Uppsala University Hospital University of Helsinki Tampere University Hospital

About

Hannaleena Eerola is an author at Helsinki University Hospital specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.2K
2	Cell Biology	3	3	364
3	Health Sciences	1	1	65
4	Public Health	1	1	65
5	Social Sciences	1	1	101

Hannaleena Eerola

Publications

Citations

H-Index

Page 1

	Year	Citations
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions Antonis C. Antoniou, Alex Cunningham, Julian Peto, British Journal of Cancer	2008	529
A CHEK2 Genetic Variant Contributing to a Substantial Fraction of Familial Breast Cancer Pia Vahteristo, Jiřina Bártková, Hannaleena Eerola, The American Journal of Human Genetics Breast OncologyMedicinePathologyFamilial Breast CancerBreast Cancer	2002	475
Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus Tommi Kainu, Suh‐Hang Hank Juo, Richard Desper, Proceedings of the National Academy of Sciences	2000	185
p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition. Pia Vahteristo, Anitta Tamminen, Petteri Karvinen, PubMed Cancer PathologyGeneticsGenetic EpidemiologyPathologyMolecular Genetics	2001	182
Breast Cancer Patients with p53 Pro72 Homozygous Genotype Have a Poorer Survival Johanna Tommiska, Hannaleena Eerola, Mira Heinonen, Clinical Cancer Research	2005	166
CHEK2 variant I157T may be associated with increased breast cancer risk Outi Kilpivaara, Pia Vahteristo, Jacob Falck, International Journal of Cancer	2004	163
Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients Outi Kilpivaara, Jiřina Bártková, Hannaleena Eerola, International Journal of Cancer	2004	118
The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer Johanna Tommiska, Jiřina Bártková, Merja Heinonen, Oncogene Genome InstabilityBreast OncologyDna DamageMedicineEr/pr/erbb2-triple-negative Breast Cancer	2007	113
A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families Pia Vahteristo, Hannaleena Eerola, Anitta Tamminen, British Journal of Cancer	2001	108
Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families Hannaleena Eerola, Päivi Heikkilä, Anitta Tamminen, Breast Cancer Research	2004	106

Page 1